RNTX

NASDAQStock

Rein Therapeutics Inc.

$1.34+0.06 (+4.69%)

52-Week Range

$1.07

$2.36

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.54

Volume

35.2K

Avg Volume

104.0K

Performance

+9.40%

-13.51%

+15.32%

YTD

+2.40%

-36.00%

-33.68%

Price Chart

ETF Exposure

RNTX is held by 7 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	36	$63	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	1,290	$2K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	6	$10	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	734,417	$955K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	3,862	$7K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	333	$586	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	264,104	$343K	$84.10B	0.05%

About RNTX ETF Exposure

Rein Therapeutics Inc. (RNTX) is held by 7 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $1.34. Investors can gain exposure to RNTX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RNTX, sorted by portfolio weight.